# New ‘Viagra for the brain’ pill slows clinical decline in Alzheimer’s patients by a third

- URL: https://talkfuse.com/story/new-viagra-for-the-brain-pill-slows-clinical-decline-in-alzheimers-patients-by-a-third/
- Published: 2026-11-16T21:09:04+00:00
- Updated: 2026-11-16T21:23:11+00:00
- Original publisher: Daily Mail (publisher lean: Right)
- Original article: https://www.dailymail.com/news/article-16297465/New-Viagra-brain-pill-slows-clinical-decline-Alzheimers-patients-third.html?ns_mchannel=rss&amp;ns_campaign=1490&amp;ito=1490
- Topics: Health, Medicine, Mental Health, World

## Key points

- AR1001 was linked to 31 per cent slower decline in one trial group.
- The phase III trial followed 1,535 people for a year.
- Further investigation is needed, especially alongside other dementia medicines.

## Summary

A phase III trial found that the once-daily tablet AR1001 was associated with slower clinical decline in people with Alzheimer’s over one year. The results are encouraging because the drug is an oral treatment designed to affect processes linked to the disease, potentially offering a simpler alternative to treatments given by infusion or injection.

The international trial included 1,535 participants at 230 sites in 13 countries, including the UK. Among people taking AR1001 without other dementia medicines, memory, thinking and daily functioning declined 31 per cent less than with placebo, equivalent to about 3.5 months; a 7 per cent difference among those taking other dementia drugs was not statistically significant. Side effects were mostly mild or moderate and were reported by 69 per cent of those given AR1001, compared with 66.4 per cent on placebo.

---
Summarised by TalkFuse (https://talkfuse.com/). Quote the original publisher for the reporting and link this page for the summary and discussion.
